Yazan Abou-Ismail: Contributing to the Future of von Willebrand Disease Management
Yazan Abou-Ismail, Associate Professor of Hematology at the University of Utah, shared a post on LinkedIn:
“Finally arrived..! My very first book chapter in a medical textbook.
Quite honored to be included among such an esteemed list of colleagues and world renowned hematologists, and very grateful to the editors and most importantly my coauthor and mentor of 10 years Peter Kouides, (who also was my mentor on my very first peer-reviewed journal publication in 2018.)
In this chapter we detail the expert management of von Willebrand Disease, the most common hereditary bleeding disorder, in different clinical settings including perioperative, obstetrical, cardiovascular and unique scenarios.
This took a huge amount of work and I’m quite excited to finally see it in hard cover! Now available with Springer Nature.”
Stay updated with Hemostasis Today.
-
Jul 12, 2026, 12:30Reduced-Dose DOACs in GI Malignancies: Toward Personalized Anticoagulation
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026